|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4741 | |
| A61K 38/17 | |||
| A61K 45/00 | |||
| A61K 39/395 |
| (11) | Number of the document | 3229803 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15816534.0 |
| Date of filing the European patent application | 2015-12-10 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/059525 |
| Date | 2015-12-10 |
| (87) | Number | WO 2016/092508 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| 201462091200 P | 2014-12-12 | US |
| (72) |
SHENG, Qing, US
JAIN, Rakesh K., US
ASKOXYLAKIS, Vasileios, US
FERRARO, Gino B., US
FUKUMURA, Dai, US
KODACK, David P., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, US |
| (54) | TREATMENT OF BREAST CANCER BRAIN METASTASES |
| TREATMENT OF BREAST CANCER BRAIN METASTASES |